CBD inhibits tau hyperphosphorylation (Esposito et al., 2006a; Vallee et al., 2017), reduces full-length APP expression, and reduces Aβ peptide expression (Scuderi et al., 2014), suggesting CBD can reduce AD pathology in cell culture. This evidence concerns the gene MAPT and Alzheimer disease.